Complexity of Stomach–Brain Interaction Induced by Molecular Hydrogen in Parkinson’s Disease Model Mice
Molecular hydrogen (H2), as a new medical gas, has protective effects in neurological disorders including Parkinson’s disease (PD). In our previous report, the neuroprotective effect of drinking water with saturated H2 (H2 water) in PD mice might be due to stomach–brain interaction via release of gastric hormone, ghrelin. In the present study, we assessed the effect of H2-induced ghrelin more precisely. To confirm the contribution of ghrelin in H2 water-drinking PD model mice, ghrelin-knock out (KO) mice were used. Despite the speculation, the effect of H2 water was still observed in ghrelin-KO PD model mice. To further check the involvement of ghrelin, possible contribution of ghrelin-induced vagal afferent effect was tested by performing subdiaphragmatic vagotomy before treating with H2 water and administration of MPTP (1-methyl- 4-phenyl-1,2,3,6-tetrahydropyridine). The protective effect of H2 water was still observed in the vagotomized mice in substantia nigra, suggesting that stimulation of vagal afferent nerves is not involved in H2-induced neuroprotection. Other neuroprotective substitutes in ghrelin-KO mice were speculated because H2-induced neuroprotection was not cancelled by ghrelin receptor antagonist, D-Lys3 GHRP-6, in ghrelin-KO PD model mice, unlike in wild-type PD model mice. Our results indicate that ghrelin may not be the only factor for H2-induced neuroprotection and other factors can substitute the role of ghrelin when ghrelin is absent, raising intriguing options of research for H2-responsive factors.
KeywordsMolecular hydrogen Parkinson’s disease Ghrelin Vagal afferents Ghrelin-knock out mice
We thank Prof. David A. Brown (UCL, UK) for reading the manuscript and Prof. Fusao Kato (Jikei University, Japan) for providing useful comments. We thank Prof. Masayasu Kojima and Dr. Takahiro Sato (Kurume University, Japan) for supplying us ghrelin-KO mice. We also thank Miss Megumi Yamafuji (Graduate School of Pharmaceutical Science, Kyushu University, Japan), Dr. Hiroko Nomaru (Medical Institute of Bioregulation, Kyushu University, Japan) for helping some of the experiments. This work was partly supported by Laboratory for Technical Supports Medical Institute of Bioregulation and the Research Support Center, Graduate School of Medical Sciences, Kyushu University.
Compliance with Ethical Standards
Conflict of interest
The authors declare no conflict of interest associated with this manuscript.
- 2.Noda M, Fujita K, Hamner MA, Yamafuji M, Akimoto N, Kido MA, Tanaka Y, Nakabeppu Y, Ransom BR (2012) Molecular hydrogen protects against central nervous system white matter ischemic injury. SfN 42nd annual meeting;660.14Google Scholar
- 5.Noda M, Fujita K, Ohsawa I, Ito M, Ohno K. (2014) Multiple effects of molecular hydrogen and its distinct mechanism. J Neurol Disord 2:6Google Scholar
- 6.Yamaguchi H, Kajitani K, Dan Y, Furuichi M, Ohno M, Sakumi K, Kang D, Nakabeppu Y (2006) MTH1, an oxidized purine nucleoside triphosphatase, protects the dopamine neurons from oxidative damage in nucleic acids caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Cell Death Differ 13:551–563CrossRefPubMedGoogle Scholar
- 9.Fujita K, Seike T, Yutsudo N, Ohno M, Yamada H, Yamaguchi H, Sakumi K, Yamakawa Y, Kido MA, Takaki A, Katafuchi T, Tanaka Y, Nakabeppu Y, Noda M (2009) Hydrogen in drinking water reduces dopaminergic neuronal loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson’s disease. PLoS ONE 4:e7247CrossRefPubMedPubMedCentralGoogle Scholar
- 10.Fu Y, Ito M, Fujita Y, Ichihara M, Masuda A, Suzuki Y, Maesawa S, Kajita Y, Hirayama M, Ohsawa I, Ohta S, Ohno K (2009) Molecular hydrogen is protective against 6-hydroxydopamine-induced nigrostriatal degeneration in a rat model of Parkinson’s disease. Neurosci Lett 453:81–85CrossRefPubMedGoogle Scholar
- 13.Ito M, Hirayama M, Yamai K, Goto S, Ichihara M, Ohno K (2012) Drinking hydrogen water and intermittent hydrogen gas exposure, but not lactulose or continuous hydrogen gas exposure, prevent 6-hydorxydopamine-induced Parkinson’s disease in rats. Med Gas Res 2:15CrossRefPubMedPubMedCentralGoogle Scholar
- 24.Andrews ZB, Erion D, Beiler R, Liu ZW, Abizaid A, Zigman J, Elsworth JD, Savitt JM, Dimarchi R, Tschoep M, Roth RH, Gao XB, Horvath TL (2009) Ghrelin promotes and protects nigrostriatal dopamine function via a UCP2-dependent mitochondrial mechanism. J Neurosci 29:14057–14065CrossRefPubMedPubMedCentralGoogle Scholar
- 26.Moon M, Kim HG, Hwang L, Seo JH, Kim S, Hwang S, Lee D, Chung H, Oh MS, Lee KT, Park S (2009) Neuroprotective effect of ghrelin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson’s disease by blocking microglial activation. Neurotox Res 15:332–347CrossRefPubMedGoogle Scholar
- 27.Noda M, Ohsawa I, Ito M, Ohno K (2014) Beneficial effects of hydrogen in the CNS and a new brain-stomach interaction. Eur J Neurodegener Dis 3:25–34Google Scholar
- 31.Moon M, Kim HG, Hwang L, Seo JH, Kim S, Hwang S, Kim S, Lee D, Chung H, Oh MS, Lee KT, Park S (2009) Neuroprotective effect of ghrelin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson’s disease by blocking microglial activation. Neurotox Res 15:332–347CrossRefPubMedGoogle Scholar
- 36.Iwasaki Y, Maejima Y, Suyama S, Yoshida M, Arai T, Katsurada K, Kumari P, Nakabayashi H, Kakei M, Yada T (2015) Peripheral oxytocin activates vagal afferent neurons to suppress feeding in normal and leptin-resistant mice: a route for ameliorating hyperphagia and obesity. Am J Physiol Regul Integr Comp Physiol 308:R360–R369CrossRefPubMedGoogle Scholar
- 38.Kajitani K, Nomaru H, Ifuku M, Yutsudo N, Dan Y, Miura T, Tsuchimoto D, Sakumi K, Kadoya T, Horie H, Poirier F, Noda M, Nakabeppu Y (2009) Galectin-1 promotes basal and kainate-induced proliferation of neural progenitors in the dentate gyrus of adult mouse hippocampus. Cell Death Differ 16:417–427CrossRefPubMedGoogle Scholar